Literature DB >> 11180000

An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.

C A Harwood1, V J Swale, V A Bataille, A G Quinn, L Ghali, S V Patel, I Dove-Edwin, R Cerio, J M McGregor.   

Abstract

Sebaceous carcinomas are rare cutaneous appendageal tumors that may occur sporadically or in association with an internal malignancy in Muir-Torre syndrome. In Muir-Torre syndrome microsatellite instability can often be demonstrated in tumor DNA as a result of an inherited mutation in one of several known mismatch repair genes; however, the role of microsatellite instability in sporadic sebaceous carcinomas has not been previously studied. In this report we describe the clinicopathologic characteristics of a series of unselected sebaceous carcinomas and examine them for the presence of microsatellite instability. Of 10 consecutive tumors identified over a 10 y period, only one was from a patient known to have Muir-Torre syndrome. Of the nine presumed sporadic cases, five were from four renal transplant recipients and four from otherwise healthy individuals. Microsatellite instability was demonstrable in three cases: in the Muir-Torre syndrome-associated tumor and in two tumors from transplant patients. Microsatellite instability was subsequently also found in a sebaceous carcinoma from a further transplant patient prospectively sought from another institution. The presence of microsatellite instability in post-transplant sebaceous carcinomas was associated with loss of expression of the mismatch repair protein hMSH2. In summary, sebaceous gland carcinomas, while characteristic of Muir-Torre syndrome, are commonly found outside this context. Among presumed sporadic cases, our data suggest they may be over-represented in immunosuppressed renal transplant recipients. The presence of microsatellite instability in transplant-associated lesions, together with loss of hMSH2 expression suggests that immunosuppression might unmask a previously silent Muir-Torre syndrome phenotype in some cases. Alternatively, there is experimental evidence to suggest that immunosuppressive drugs, most plausibly azathioprine, could select for the emergence of a mutator phenotype and thus predispose to the development of sebaceous carcinomas. The role of mismatch repair defects in other post-transplant skin malignancies remains to be established.

Entities:  

Mesh:

Year:  2001        PMID: 11180000     DOI: 10.1046/j.1523-1747.2001.01233.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

Review 1.  Genetics of skin appendage neoplasms and related syndromes.

Authors:  D A Lee; M E Grossman; P Schneiderman; J T Celebi
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

Review 2.  Sebaceous Carcinoma: A Review of the Scientific Literature.

Authors:  Thomas Knackstedt; Faramarz H Samie
Journal:  Curr Treat Options Oncol       Date:  2017-08

3.  Muir-Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients.

Authors:  G Ponti; G Pellacani; C Ruini; A Percesepe; C Longo; V Desmond Mandel; F Crucianelli; G Gorelli; A Tomasi
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

4.  Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway.

Authors:  Eduardo Vilar; Bhramar Mukherjee; Rork Kuick; Leon Raskin; David E Misek; Jeremy M G Taylor; Thomas J Giordano; Samir M Hanash; Eric R Fearon; Gad Rennert; Stephen B Gruber
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

5.  Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms.

Authors:  Maegan E Roberts; Douglas L Riegert-Johnson; Brittany C Thomas; Colleen S Thomas; Michael G Heckman; Murli Krishna; David J DiCaudo; Alina G Bridges; Katherine S Hunt; Kandelaria M Rumilla; Mark A Cappel
Journal:  J Genet Couns       Date:  2012-12-06       Impact factor: 2.537

6.  Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients.

Authors:  Peter Schleier; Peter Hyckel; Alexander Berndt; Hans-Peter Bode; Volker Albrecht; Winfried Hindermann; Hartwig Kosmehl; Witold Zenk; Dieter Schumann
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-02       Impact factor: 4.553

7.  Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults.

Authors:  Emilie Lanoy; Dominique Costagliola; Eric A Engels
Journal:  Int J Cancer       Date:  2010-04-01       Impact factor: 7.396

8.  Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome.

Authors:  Graça M Dores; Rochelle E Curtis; Jorge R Toro; Susan S Devesa; Joseph F Fraumeni
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

9.  Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.

Authors:  Emilie Lanoy; Graça M Dores; Margaret M Madeleine; Jorge R Toro; Joseph F Fraumeni; Eric A Engels
Journal:  AIDS       Date:  2009-01-28       Impact factor: 4.177

10.  Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.

Authors:  Michael R Sargen; Elizabeth K Cahoon; Charles F Lynch; Margaret A Tucker; Alisa M Goldstein; Eric A Engels
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.